Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

M. Affer, Marta Chesi, W. D. Chen, J. J. Keats, Y. N. Demchenko, K. Tamizhmani, V. M. Garbitt, D. L. Riggs, L. A. Brents, A. V. Roschke, S. Van Wier, Rafael Fonseca, Peter Leif Bergsagel, W. M. Kuehl

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

MYC locus rearrangements - often complex combinations of translocations, insertions, deletions and inversions - in multiple myeloma (MM) were thought to be a late progression event, which often did not involve immunoglobulin genes. Yet, germinal center activation of MYC expression has been reported to cause progression to MM in an MGUS (monoclonal gammopathy of undetermined significance)-prone mouse strain. Although previously detected in 16% of MM, we find MYC rearrangements in nearly 50% of MM, including smoldering MM, and they are heterogeneous in some cases. Rearrangements reposition MYC near a limited number of genes associated with conventional enhancers, but mostly with super-enhancers (e.g., IGH, IGL, IGK, NSMCE2, TXNDC5, FAM46C, FOXO3, IGJ, PRDM1). MYC rearrangements are associated with a significant increase of MYC expression that is monoallelic, but MM tumors lacking a rearrangement have biallelic MYC expression at significantly higher levels than in MGUS. We also have shown that germinal center activation of MYC does not cause MM in a mouse strain that rarely develops spontaneous MGUS. It appears that increased MYC expression at the MGUS/MM transition usually is biallelic, but sometimes can be monoallelic if there is an MYC rearrangement. Our data suggest that MYC rearrangements, regardless of when they occur during MM pathogenesis, provide one event that contributes to tumor autonomy.

Original languageEnglish (US)
Pages (from-to)1725-1735
Number of pages11
JournalLeukemia
Volume28
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance
Germinal Center
Immunoglobulin Genes
Neoplasms
Genes

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. / Affer, M.; Chesi, Marta; Chen, W. D.; Keats, J. J.; Demchenko, Y. N.; Tamizhmani, K.; Garbitt, V. M.; Riggs, D. L.; Brents, L. A.; Roschke, A. V.; Van Wier, S.; Fonseca, Rafael; Bergsagel, Peter Leif; Kuehl, W. M.

In: Leukemia, Vol. 28, No. 8, 2014, p. 1725-1735.

Research output: Contribution to journalArticle

Affer, M, Chesi, M, Chen, WD, Keats, JJ, Demchenko, YN, Tamizhmani, K, Garbitt, VM, Riggs, DL, Brents, LA, Roschke, AV, Van Wier, S, Fonseca, R, Bergsagel, PL & Kuehl, WM 2014, 'Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma', Leukemia, vol. 28, no. 8, pp. 1725-1735. https://doi.org/10.1038/leu.2014.70
Affer, M. ; Chesi, Marta ; Chen, W. D. ; Keats, J. J. ; Demchenko, Y. N. ; Tamizhmani, K. ; Garbitt, V. M. ; Riggs, D. L. ; Brents, L. A. ; Roschke, A. V. ; Van Wier, S. ; Fonseca, Rafael ; Bergsagel, Peter Leif ; Kuehl, W. M. / Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. In: Leukemia. 2014 ; Vol. 28, No. 8. pp. 1725-1735.
@article{d940b2383eb540bfa0362ea2314776d2,
title = "Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma",
abstract = "MYC locus rearrangements - often complex combinations of translocations, insertions, deletions and inversions - in multiple myeloma (MM) were thought to be a late progression event, which often did not involve immunoglobulin genes. Yet, germinal center activation of MYC expression has been reported to cause progression to MM in an MGUS (monoclonal gammopathy of undetermined significance)-prone mouse strain. Although previously detected in 16{\%} of MM, we find MYC rearrangements in nearly 50{\%} of MM, including smoldering MM, and they are heterogeneous in some cases. Rearrangements reposition MYC near a limited number of genes associated with conventional enhancers, but mostly with super-enhancers (e.g., IGH, IGL, IGK, NSMCE2, TXNDC5, FAM46C, FOXO3, IGJ, PRDM1). MYC rearrangements are associated with a significant increase of MYC expression that is monoallelic, but MM tumors lacking a rearrangement have biallelic MYC expression at significantly higher levels than in MGUS. We also have shown that germinal center activation of MYC does not cause MM in a mouse strain that rarely develops spontaneous MGUS. It appears that increased MYC expression at the MGUS/MM transition usually is biallelic, but sometimes can be monoallelic if there is an MYC rearrangement. Our data suggest that MYC rearrangements, regardless of when they occur during MM pathogenesis, provide one event that contributes to tumor autonomy.",
author = "M. Affer and Marta Chesi and Chen, {W. D.} and Keats, {J. J.} and Demchenko, {Y. N.} and K. Tamizhmani and Garbitt, {V. M.} and Riggs, {D. L.} and Brents, {L. A.} and Roschke, {A. V.} and {Van Wier}, S. and Rafael Fonseca and Bergsagel, {Peter Leif} and Kuehl, {W. M.}",
year = "2014",
doi = "10.1038/leu.2014.70",
language = "English (US)",
volume = "28",
pages = "1725--1735",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

AU - Affer, M.

AU - Chesi, Marta

AU - Chen, W. D.

AU - Keats, J. J.

AU - Demchenko, Y. N.

AU - Tamizhmani, K.

AU - Garbitt, V. M.

AU - Riggs, D. L.

AU - Brents, L. A.

AU - Roschke, A. V.

AU - Van Wier, S.

AU - Fonseca, Rafael

AU - Bergsagel, Peter Leif

AU - Kuehl, W. M.

PY - 2014

Y1 - 2014

N2 - MYC locus rearrangements - often complex combinations of translocations, insertions, deletions and inversions - in multiple myeloma (MM) were thought to be a late progression event, which often did not involve immunoglobulin genes. Yet, germinal center activation of MYC expression has been reported to cause progression to MM in an MGUS (monoclonal gammopathy of undetermined significance)-prone mouse strain. Although previously detected in 16% of MM, we find MYC rearrangements in nearly 50% of MM, including smoldering MM, and they are heterogeneous in some cases. Rearrangements reposition MYC near a limited number of genes associated with conventional enhancers, but mostly with super-enhancers (e.g., IGH, IGL, IGK, NSMCE2, TXNDC5, FAM46C, FOXO3, IGJ, PRDM1). MYC rearrangements are associated with a significant increase of MYC expression that is monoallelic, but MM tumors lacking a rearrangement have biallelic MYC expression at significantly higher levels than in MGUS. We also have shown that germinal center activation of MYC does not cause MM in a mouse strain that rarely develops spontaneous MGUS. It appears that increased MYC expression at the MGUS/MM transition usually is biallelic, but sometimes can be monoallelic if there is an MYC rearrangement. Our data suggest that MYC rearrangements, regardless of when they occur during MM pathogenesis, provide one event that contributes to tumor autonomy.

AB - MYC locus rearrangements - often complex combinations of translocations, insertions, deletions and inversions - in multiple myeloma (MM) were thought to be a late progression event, which often did not involve immunoglobulin genes. Yet, germinal center activation of MYC expression has been reported to cause progression to MM in an MGUS (monoclonal gammopathy of undetermined significance)-prone mouse strain. Although previously detected in 16% of MM, we find MYC rearrangements in nearly 50% of MM, including smoldering MM, and they are heterogeneous in some cases. Rearrangements reposition MYC near a limited number of genes associated with conventional enhancers, but mostly with super-enhancers (e.g., IGH, IGL, IGK, NSMCE2, TXNDC5, FAM46C, FOXO3, IGJ, PRDM1). MYC rearrangements are associated with a significant increase of MYC expression that is monoallelic, but MM tumors lacking a rearrangement have biallelic MYC expression at significantly higher levels than in MGUS. We also have shown that germinal center activation of MYC does not cause MM in a mouse strain that rarely develops spontaneous MGUS. It appears that increased MYC expression at the MGUS/MM transition usually is biallelic, but sometimes can be monoallelic if there is an MYC rearrangement. Our data suggest that MYC rearrangements, regardless of when they occur during MM pathogenesis, provide one event that contributes to tumor autonomy.

UR - http://www.scopus.com/inward/record.url?scp=84905705842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905705842&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.70

DO - 10.1038/leu.2014.70

M3 - Article

VL - 28

SP - 1725

EP - 1735

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 8

ER -